Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chemo-enzymatic route for Eluxadoline intermediate. High yield, scalable, cost-effective pharmaceutical intermediates manufacturing for global supply chains.
Patent CN110117254B reveals a streamlined 3-step route for Cabozantinib, replacing hazardous nitration with efficient one-pot reduction and copper-catalyzed decarboxylation for superior supply chain stability.
Novel C2 symmetric tetrahydropyrimidine synthesis. High yield, scalable route for asymmetric catalysis intermediates.
Novel Pd-catalyzed synthesis of ester-modified silacyclohexanes. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110511159A offers high-purity Benserazide Hydrochloride synthesis avoiding DMF solvents for cost-effective pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN120383620A reveals Pd-catalyzed synthesis of chiral silacyclohexanes. Enables cost reduction in pharmaceutical intermediate manufacturing with high purity.
Patent CN109182298B details engineered lipase mutants for high-efficiency resolution of moxifloxacin intermediates, offering significant cost reduction and supply chain reliability.
Patent CN115894326B reveals Rhodium-catalyzed synthesis for high-purity aminoindole derivatives. Safe vinylene carbonate route offers substantial supply chain and cost advantages.
Electrochemical synthesis patent CN117660991A enables high-purity pharmaceutical intermediates with reduced costs and enhanced supply chain reliability for global buyers.
Novel Ru-BINAP catalyzed route for (R)-5'-methoxylaudanosine. High purity >99.98% ee, non-genotoxic process, scalable for Mivacurium Chloride production.
Patent CN101693738B reveals a green solid-phase oxidation method for Terlipressin, offering higher yields and reduced waste for reliable API manufacturing.
Advanced Sharpless epoxidation process for (S)-beta-hydroxy-gamma-butyrolactone. Delivers high enantiomeric excess and cost-effective supply chain solutions for pharmaceutical manufacturing.
Patent CN1016689B details a novel synthesis for gastric ulcer intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN111116593A details a continuous, low-cost Ibrutinib synthesis featuring raw material recycling and simplified purification for scalable pharmaceutical manufacturing.
Novel fragment method for linaclotide preparation ensures high purity and scalable production for global supply chains.
Advanced synthesis of high-purity 3-methylamine tetrahydrofuran via reductive amination. Optimized for Dinotefuran production with superior moisture control and cost efficiency.
Patent CN107552089A reveals low-cost squaramide catalyst for high-purity tetrahydro-beta-carboline derivatives ensuring supply chain stability.
Novel radical coupling route for Crisaborole reduces cost and complexity significantly. Reliable pharmaceutical intermediates supplier offering scalable solutions for global demand.
Novel patent CN113173987B enables high-purity lixisenatide production with reduced purification complexity and enhanced supply chain reliability for global pharmaceutical partners.
Novel continuous method for Ibrutinib reducing TPP waste and enabling raw material recycling for cost-effective API manufacturing.